Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience
- PMID: 37985495
- DOI: 10.1080/09546634.2023.2285243
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience
MeSH terms
Substances
LinkOut - more resources
Full Text Sources